Information Technology in Pharma: Digital Backbone for Compliance and Innovation
Pharma IT spans the entire product lifecycle — from discovery to distribution. Common IT systems include:Click to read the full article.
Information Technology (IT)
IT System Failures and Audit Findings? GxP IT Solutions
Recognizing the early symptoms that signal an IT system failure is vital for initiating a timely response. Common indicators may include:Click to read the full article.
System access control failure during system upgrades – inspection evidence pack preparation
Detection of system access control failures can often be subtle, with signs appearing in logs or through user complaints. Common symptoms include:Click to read the full article.
Audit trail gaps identified during system upgrades – FDA/EMA expectations for computerized systems
Identifying symptoms or signals that may indicate audit trail gaps during system upgrades is crucial for timely intervention. Common indicators include:Click to read the full article.
Patch management weaknesses during validation lifecycle – FDA/EMA expectations for computerized systems
Understanding Patch Management Weaknesses in the Validation Lifecycle: FDA and EMA Considerations In a highly regulated industry like pharmaceuticals, ensuring that computerized systems remain compliant throughout their lifecycle is paramount.…
CSV not aligned to actual use during system operation – inspection evidence pack preparation
Identifying symptoms or signals that indicate a misalignment of CSV is the first step in the investigation process. These can manifest in various ways, including:Click to read the full article.
Interface validation gaps during data integrity review – FDA/EMA expectations for computerized systems
Recognizing symptoms of interface validation gaps is critical in the pharmaceutical environment. Symptoms may manifest in several areas, including:Click to read the full article.
Patch management weaknesses during system upgrades – data integrity risk and remediation
Recognizing early symptoms of patch management weaknesses is pivotal. Symptoms may not only emerge in IT but can also cascade into production areas, affecting quality assurance and regulatory compliance. Common…
Interface validation gaps during system upgrades – CAPA and revalidation strategy
Identifying symptoms or signals indicative of validation gaps is the first step in addressing potential issues. Common symptoms may include:Click to read the full article.
Interface validation gaps during system operation – CAPA and revalidation strategy
Identifying symptoms indicative of interface validation gaps is the first critical step in the investigation process. Symptoms may manifest in various forms and can often be overlooked if not carefully…
Patch management weaknesses during inspection walkthrough – data integrity risk and remediation
Identifying and Addressing Patch Management Weaknesses During Inspection Walkthroughs Poor patch management can expose pharmaceutical manufacturers to significant compliance risks, particularly during regulatory inspections conducted by agencies such as the…
Audit trail gaps identified during data integrity review – inspection evidence pack preparation
Identifying symptoms related to audit trail gaps is crucial for timely intervention. Here are common signs that may indicate issues with data integrity:Click to read the full article.